3D printing start-up, Remedy Health, and pharma-tech experts, FabRx, will work together on the innovative research and thanks to the grant, the bespoke medicine is estimated to be launched in 2020.
The need for such medication has arisen following limitations of generic manufactured doses which is believed to have resulted in incorrect dosing in cases involving children.
According to World Health Organisation, less than one third of medicines have a form appropriate for children. In first world countries, more than half of children have taken drugs that are not approved for them.
The 3D printed medication will make it possible to create bespoke, personalised doses and sizes of medication depending on each individual patient and their needs.
The system will allow manufacture of bespoke medications with unique properties, better designed to meet the needs of patients”
Dr Alvaro Goyanes, director of development for FabRx says: “Having pioneered the concept of 3D printing of oral pharmaceutical products, FabRx is delighted to partner with Remedy Health in the development of a unique and truly innovative system specially designed to meet the demanding requirements of the pharmaceutical industry.
“The system will allow manufacture of bespoke medications with unique properties, better designed to meet the needs of patients.”
The new medication will also come in personalised flavours and shapes to add more enjoyment to the process and encourage young children to take their medication.
“We are thrilled to be able to use our patented 3D printing technology to provide an improved experience to medical patients all over the world,” adds Melissa Snover, chief executive officer of Remedy Health.
“Our vision to create personalised medication will revolutionise the way people take medication and make their treatment more accurate, more efficient and more enjoyable.”
If you have any news, please email carys@linkpublishing.co.uk or join in with the conversation on Twitter.